Evidence map›Paper›PMID 42362533›Full record

ArticleNature communications2026

Retraction Note: Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance.

Hai Wang, Zan Gao, Xuanyou Liu, Pranay Agarwal, Shuting Zhao, Daniel W Conroy, Guang Ji, Jianhua Yu, Christopher P Jaroniec, Zhenguo Liu and 3 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Hai WangDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Zan GaoDepartment of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0003-3047-5616
Xuanyou LiuDivision of Cardiovascular Medicine, Center for Precision Medicine, University of Missouri School of Medicine, Columbia, MO, 65212, USA.
Pranay AgarwalDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Shuting ZhaoDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Daniel W ConroyDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.
Guang JiInstitute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.ORCID https://orcid.org/0000-0003-0842-3676
Jianhua YuComprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.
Christopher P JaroniecDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, 43210, USA.ORCID https://orcid.org/0000-0003-0364-2888
Zhenguo LiuDavis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Xiongbin LuDepartment of Medical and Molecular Genetics and Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Xiaodong LiDepartment of Mechanical and Aerospace Engineering, University of Virginia, Charlottesville, VA, USA. xl3p@virginia.edu.
Xiaoming HeDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA. shawnhe@umd.edu.ORCID https://orcid.org/0000-0003-0125-6086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42362533
PMCPMC13309521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.